Dual dopamine agonist treatment in Parkinson’s disease

A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa

2000 • 1,513 citations

What features improve the accuracy of clinical diagnosis in Parkinson's disease

1992 • 1,232 citations

Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial

2000 • 817 citations

Dyskinesias and motor fluctuations in Parkinson's disease

2000 • 581 citations

A rating scale for tardive dyskinesia

1979 • 389 citations

Bromocriptine in Parkinsonism

1974 • 311 citations

Cabergoline in the treatment of early parkinson's disease

1997 • 129 citations

Placebo‐associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's disease

2002 • 128 citations

L -Dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations

2001 • 105 citations

Pergolide monotherapy in the treatment of early PD

1999 • 104 citations

The placebo response in Parkinson's disease. Parkinson Study Group.

1999 • 97 citations

Antiparkinsonian activity and dyskinesia risk of ropinirole and L‐DOPA combination therapy in drug naive MPTP‐lesioned common marmosets (Callithrix jacchus)

2001 • 90 citations

Low dosages of bromocriptine added to levodopa in Parkinson's disease

1985 • 66 citations

Pharmacodynamic and Pharmacokinetic Features of Cabergoline

1998 • 60 citations

Dopamine Agonists in the Treatment of Parkinsons Disease-Past, Present and Future

2000 • 39 citations

Clinical Experience with Cabergoline in Patients with Advanced Parkinson??s Disease Treated with Levodopa

1998 • 38 citations

Dopaminergic agonists in Parkinsonism.

1975 • 14 citations

Dopamine Agonists in Parkinson???s Disease

1998 • 12 citations